Reply to: STRIDE's Efficacy and Safety in Asian Hepatocellular Carcinoma. Lau G, Abou-Alfa GK, Chan SL. J Hepatol 2025 Feb 28:S0168-8278(25)00146-1. doi: 10.1016/j.jhep.2025.

Read + Share

Amedeo Smart

Independent Medical Education

Lau G, Abou-Alfa GK, Chan SL. Reply to: STRIDE's Efficacy and Safety in Asian Hepatocellular Carcinoma. J Hepatol 2025 Feb 28:S0168-8278(25)00146-1. doi: 10.1016/j.jhep.2025.
PMID: 40024547